[Association between high expression of intrahepatic programmed death-1 and liver inflammation in patients with autoimmune hepatitis]

Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):263-267. doi: 10.3760/cma.j.issn.1007-3418.2017.04.006.
[Article in Chinese]

Abstract

Objective: To investigate the expression of programmed death-1 (PD-1) in liver tissue and its association with liver pathology in patients with autoimmune hepatitis (AIH). Methods: A total of 54 AIH patients (38 in the active stage and 16 in the remission stage) were enrolled, and 9 healthy volunteers were enrolled as control group. Immunohistochemistry combined with quantitative image analysis was used to measure the expression of PD-1 in liver tissue. The t-test, rank sum test, one-way analysis of variance, least significant difference t-test, Mann-Whitney U test, and Pearson relation analysis were used for statistical analysis of different types of data. Results: The AIH group had a significantly higher positive rate of PD-1 in liver tissue than the control group (13.57%±6.84% vs 2.22%±0.66%, P < 0.01), and the patients in the active stage of AIH had a significantly higher positive rate of PD-1 in liver tissue than those in the remission stage (16.53%±7.72% vs 6.56%±3.16%, P < 0.01). The positive rate of PD-1 in liver tissue was 6.56%±3.16% in G0 group, 14.33%±5.08% in G1-2 group, and 19.23%±5.41% in G3-4 group (P < 0.01), but there was no significant difference in the positive rate of PD-1 between S0, S1-2, and S3-4 groups (P > 0.05). In AIH patients, the positive rate of PD-1 in liver tissue was positively correlated with the levels of total bilirubin, alanine aminotransferase, aspartate aminotransferase, and IgG (r = 0.665, 0.721, 0.711, and 0.813, all P < 0.01). Conclusion: AIH patients have regulated PD-1 expression in liver tissue, which is closely associated with liver inflammation and is not associated with fibrosis degree, suggesting that PD-1 is involved in the development and progression of inflammation in AIH patients.

目的: 研究自身免疫性肝炎(AIH)患者肝组织中程序性死亡受体1(PD-1)的表达情况,并探讨其与肝脏病理的相关性。 方法: 收集54例AIH患者(活动期38例和缓解期16例),并选择9例健康者为对照组。采用免疫组织化学方法结合图像定量分析系统检测肝组织中PD-1的表达。据资料不同分别采用t检验、秩和检验、单因素方差分析及LSD-t检验、Mann-Whitney U及Pearson相关分析进行统计学分析。 结果: AIH患者肝组织PD-1阳性表达率高于对照组(13.57%±6.84%对比2.22%±0.66%,P < 0.01);AIH活动期肝组织PD-1阳性表达率高于缓解期(16.53%±7.72%对比6.56%±3.16%,P < 0.01)。G0组、G1~2组及G3~4组AIH患者肝组织中PD-1阳性表达率逐渐升高,分别为6.56%±3.16%、14.33%±5.08%、19.23%±5.41%(P < 0.01),而S0组、S1~2组及S3~4组AIH患者肝组织中PD-1阳性表达率则无差异(P > 0.05)。AIH患者肝组织PD-1阳性表达率与总胆红素、丙氨酸氨基转移酶、天冬氨酸氨基转移酶及IgG水平均呈正相关(r分别是0.665、0.721、0.711、0.813,P < 0.01)。 结论: AIH患者肝组织PD-1表达上调,与肝组织炎症活动密切相关,但与纤维化分级无相关性,提示PD-1参与了AIH炎症的发生及发展。.

Keywords: Autoimmune hepatitis; Liver pathology; Programmed cell death receptor 1.

MeSH terms

  • Alanine Transaminase
  • Aspartate Aminotransferases / blood*
  • Case-Control Studies
  • Hepatitis, Autoimmune / diagnosis
  • Hepatitis, Autoimmune / metabolism*
  • Humans
  • Inflammation / immunology*
  • Programmed Cell Death 1 Receptor / immunology*
  • Programmed Cell Death 1 Receptor / physiology

Substances

  • Programmed Cell Death 1 Receptor
  • Aspartate Aminotransferases
  • Alanine Transaminase